1. Home
  2. HRB vs LEGN Comparison

HRB vs LEGN Comparison

Compare HRB & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H&R Block Inc.

HRB

H&R Block Inc.

HOLD

Current Price

$43.30

Market Cap

7.5B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$22.85

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRB
LEGN
Founded
1955
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HRB
LEGN
Price
$43.30
$22.85
Analyst Decision
Sell
Strong Buy
Analyst Count
2
13
Target Price
$55.00
$69.58
AVG Volume (30 Days)
1.7M
2.6M
Earning Date
02-03-2026
11-12-2025
Dividend Yield
3.91%
N/A
EPS Growth
9.63
N/A
EPS
4.50
N/A
Revenue
$3,770,736,000.00
$909,045,000.00
Revenue This Year
$4.28
$68.83
Revenue Next Year
$3.14
$51.27
P/E Ratio
$9.53
N/A
Revenue Growth
4.15
74.75
52 Week Low
$41.17
$21.19
52 Week High
$64.62
$45.30

Technical Indicators

Market Signals
Indicator
HRB
LEGN
Relative Strength Index (RSI) 46.54 32.41
Support Level $42.66 $21.19
Resistance Level $43.92 $28.97
Average True Range (ATR) 0.97 1.19
MACD 0.38 0.01
Stochastic Oscillator 65.73 19.41

Price Performance

Historical Comparison
HRB
LEGN

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: